iRhythm Zio Patch
An algorithm trained on a deep neural network was able to perform on par with board certified cardiologist when annotating 12 different types of heart rhythms.
iRhythm Technologies reported a promising second quarter from a financial standpoint, citing a revenue of $35.
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning.
iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm.